ATAI ATAI Life Sciences N.V. Common Shares PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

ATAI Stock Analysis: Buy, Sell, or Hold?

$7.35
+0.06 (+0.82%) ▲
5d: +0.0% 30d: +1.94% 90d: +94.44%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
44/100
Position
FAIR
Forward P/E & Valuation
-15.0x
Next 12M consensus est.
Wall Street Target
$8.10
+10.2% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$7.23 / $7.43
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: ATAI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When ATAI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ATAI is currently trading at $7.35, which is considered fair based on recent price action.

Technical Outlook: Technically, ATAI is in a strong uptrend. The price is currently testing key support at $7.23. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: ATAI scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.10 (+10.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 44/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 42.1%

Trading Range & Key Levels

Support Level $7.23
Resistance Level $7.43
Current Trend Strong Uptrend
Technical data as of Sep 10, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (29/100)
  • BULLISH: Trading below Wall St target ($8.10)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -15.00
Wall Street Target $8.10 (+10.2%)
Revenue Growth (YoY) 137.0%
Earnings Growth (YoY) -96.8%
Share ATAI Analysis

Share this live ATAI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ATAI)

Bearish 3 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 14, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish sentiment was observed on StockTwits regarding $ATAI, with one user expressing anticipation for the company following a question and answer session at the Canaccord Genuity conference for $CMPS.
Key Retail Themes: Upcoming conference for related companies Positive sentiment towards $ATAI
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:28 PM ET
Data refreshes hourly during market hours. Next update: 9:28 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ATAI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
25 analysts
$261 53 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 41 HOLD
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$32 51 HOLD
GPCR
Structure Therapeutics Iâ€Ļ
STRONG BUY
16 analysts
$107 50 HOLD
SNDX
Syndax Pharmaceuticals Iâ€Ļ
STRONG BUY
12 analysts
$35 60 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ATAI Research Pages
ATAI Technical Chart ATAI Price Prediction ATAI Intrinsic Value DCF ATAI Earnings Date ATAI Investment Advisor ATAI Fair Price Analyzer ATAI Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals